An Integrated Whole-Genome Sequencing and In-House Targeted Testing Strategy Enhances Comprehensive Mutation Detection in Neurofibromatosis Type 1
- DOI
- 10.4103/aian.aian_172_26
- Published
- 2026-08-12
- Container
- Annals of Indian Academy of Neurology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4103/aian.aian_172_26,
title = {An Integrated Whole-Genome Sequencing and In-House Targeted Testing Strategy Enhances Comprehensive Mutation Detection in Neurofibromatosis Type 1},
author = {Rekha Aaron and Kushagra Agarwal and Aaron Chapla and G Paramasivam and Dharshini Sathishkumar and Lydia Mathew and Anju George and Leni George and Thomas Palocaren and Ajit Sivadasan and Maya Thomas and Sumita Danda},
year = {2026},
journal = {Annals of Indian Academy of Neurology},
doi = {10.4103/aian.aian_172_26},
url = {https://doi.org/10.4103/aian.aian_172_26}
}RIS
TY - JOUR TI - An Integrated Whole-Genome Sequencing and In-House Targeted Testing Strategy Enhances Comprehensive Mutation Detection in Neurofibromatosis Type 1 AU - Rekha Aaron AU - Kushagra Agarwal AU - Aaron Chapla AU - G Paramasivam AU - Dharshini Sathishkumar AU - Lydia Mathew AU - Anju George AU - Leni George AU - Thomas Palocaren AU - Ajit Sivadasan AU - Maya Thomas AU - Sumita Danda PY - 2026 JO - Annals of Indian Academy of Neurology DO - 10.4103/aian.aian_172_26 UR - https://doi.org/10.4103/aian.aian_172_26 ER -
APA
Aaron, R., Agarwal, K., Chapla, A., Paramasivam, G., Sathishkumar, D., Mathew, L., George, A., George, L., Palocaren, T., Sivadasan, A., Thomas, M., & Danda, S. (2026). An Integrated Whole-Genome Sequencing and In-House Targeted Testing Strategy Enhances Comprehensive Mutation Detection in Neurofibromatosis Type 1. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_172_26
Source records
- crossref · retrieved 2026-09-26T13:10:06.009Z